Manchester University Nhs Foundation Trust
Clinical trials sponsored by Manchester University Nhs Foundation Trust, explained in plain language.
-
Could a Copper-Binding drug shrink thickened heart muscle?
Disease control CompletedThis study tested whether the drug trientine can reduce heart muscle thickening and improve exercise ability in people with hypertrophic cardiomyopathy (HCM), a condition where the heart muscle becomes abnormally thick. 154 adults with HCM took either trientine or a placebo for 1…
Phase: PHASE2 • Sponsor: Manchester University NHS Foundation Trust • Aim: Disease control
Last updated Jun 17, 2026 12:09 UTC
-
Could a tiny leg patch replace bulky boots to stop deadly clots in the ICU?
Prevention CompletedThis study tested whether a small, wearable device called geko can help prevent dangerous blood clots in the legs of critically ill adults. The geko device uses mild electrical pulses to stimulate leg muscles, improving blood flow. Researchers compared it to standard compression …
Phase: NA • Sponsor: Manchester University NHS Foundation Trust • Aim: Prevention
Last updated Jun 18, 2026 11:52 UTC
-
Can a protein fluid help septic shock patients? small study tests the waters
Knowledge-focused CompletedThis study looked at whether giving a concentrated protein fluid called albumin, along with standard fluids, is possible in patients with septic shock (a life-threatening infection causing very low blood pressure). 47 adults took part to see if doctors could recruit enough patien…
Phase: PHASE2, PHASE3 • Sponsor: Manchester University NHS Foundation Trust • Aim: Knowledge-focused
Last updated Jun 09, 2026 12:07 UTC